Nov 19, 2019 / 04:30PM GMT
Frederick Allen Wise - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research Analyst
Good morning, again. I think it's still morning. If not, good afternoon. A little early. I am thrilled, as always, to welcome my friends from Boston Scientific: Dan Brennan, Executive Vice President and Chief Financial Officer; and Susie Lisa, the wonderful Head of Investor Relations at Boston Scientific.
Questions and Answers:
Frederick Allen Wise - Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Equity Research AnalystAnd Dan, just there's so many topics. Let's just quickly just before we dive into the topics du jour and some of the specific growth drivers, let's just talk briefly at a high level about some of the puts and takes as we think about next year. I mean you -- first half of '19 was not what you wanted. You're accelerating as expected -- thank you -- in the second half, you've got easy comps to start out next year, tougher now, hopefully, for the full second half of 2020. But just